Tsung-Pei Tsou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tsung-Pei Tsou has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Chieh-Yu Lin
2 shared publicationsMing-Tsan Liu
Centers for Disease Control, Ministry of Health and Welfare, Taipei, Taiwan, ROC
2 shared publicationsChan-Hsien Chiu
Epidemic Intelligence Center
1 shared publication- Chen-Yen Tsai
Department of Pediatrics, China Medical University Beigang Hospital, Yunlin, Taiwan
1 shared publication Cheng-Chung Liu
1 shared publication- Chia-Ping Su
Department of Infectious Disease, New Taipei Municipal Tucheng Hospital, New Taipei City, Taiwan; School of Medicine, National Tsing Hua University, Hsinchu, Taiwan
1 shared publication
Latest Publications
- Open Access
- 20 July 2026
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 20 (7)
Serological Surveillance of Avian Influenza Virus Exposure Using Paired Sera Among Occupational Contacts in Taiwan, January–September 2025
In 2025, Taiwan implemented paired sera surveillance among occupational contacts of avian influenza viruses (AIVs). Of 122 contacts analyzed, 117 (95.9%) remained asymptomatic with high personal protective equipment compliance (91.8%). No seroconversion was detected against AIV A(H5N2) clade 2.3.4.4b. These findings suggest a low risk of human infection despite persistent poultry outbreaks, provide timely serological evidence during the ongoing outbreak, and demonstrate the effectiveness of Taiwan's integrated human‐animal surveillance in early risk characterization.
- 20 July 2026
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 20 (7)
Open AccessSerological Surveillance of Avian Influenza Virus Exposure Using Paired Sera Among Occupational Contacts in Taiwan, January–September 2025
In 2025, Taiwan implemented paired sera surveillance among occupational contacts of avian influenza viruses (AIVs). Of 122 contacts analyzed, 117 (95.9%) remained asymptomatic with high personal protective equipment compliance (91.8%). No seroconversion was detected against AIV A(H5N2) clade 2.3.4.4b. These findings suggest a low risk of human infection despite persistent poultry outbreaks, provide timely serological evidence during the ongoing outbreak, and demonstrate the effectiveness of Taiwan's integrated human‐animal surveillance in early risk characterization.
- Open Access
- 23 June 2026
- Published by Elsevier in SSRN Electronic Journal
Influenza Vaccine Effectiveness Against Influenza-Related Medical Visits, Hospitalization and Death Among Adults aged 65 Years and Older in Taiwan: 2024-2025 Season
Background: The 2024–2025 influenza season in Taiwan witnessed a significant 50% increase in severe cases and associated deaths compared to the prior season. This study aimed to evaluate vaccine effectiveness (VE) in this high-burden season.Methods: Building upon a validated methodological framework from our previous research, we employed a multi-database linkage approach to conduct a population-based cohort study. We assessed VE against laboratory-confirmed influenza outcomes among the elderly population ≥65 years, adjusting for age, sex, and pre-existing comorbidities through multivariable logistic regression. Index-date aligned propensity score matching was used as sensitivity analysis.Results: Despite a notable decline in vaccination coverage—dropping to 48.1% for the elderly—the vaccine demonstrated robust protection against severe outcomes. The adjusted VE was 71.9% (95% CI: [63.0-78.8]) against 30-day mortality and 70.0% (95% CI: [62.1-76.2]) against ICU admissions. Protection against influenza-associated hospitalizations was 58.2% (95% CI: [52.9-62.9]), while VE against outpatient visits was 44.8% (95% CI: [42.4-47.1]). Propensity score matching showed similar trend but generally lower VE estimates.Conclusions: Our findings confirm that the influenza vaccine remains highly effective in preventing severe outcomes, despite the reduced population uptake and increased disease burden. The methodology, consistent with our prior season’s analysis, underscores the reliability of these results. We conclude that enhancing vaccination coverage among the elderly is critical to mitigating the impact of severe seasonal epidemics.
- 23 June 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessInfluenza Vaccine Effectiveness Against Influenza-Related Medical Visits, Hospitalization and Death Among Adults aged 65 Years and Older in Taiwan: 2024-2025 Season
Background: The 2024–2025 influenza season in Taiwan witnessed a significant 50% increase in severe cases and associated deaths compared to the prior season. This study aimed to evaluate vaccine effectiveness (VE) in this high-burden season.Methods: Building upon a validated methodological framework from our previous research, we employed a multi-database linkage approach to conduct a population-based cohort study. We assessed VE against laboratory-confirmed influenza outcomes among the elderly population ≥65 years, adjusting for age, sex, and pre-existing comorbidities through multivariable logistic regression. Index-date aligned propensity score matching was used as sensitivity analysis.Results: Despite a notable decline in vaccination coverage—dropping to 48.1% for the elderly—the vaccine demonstrated robust protection against severe outcomes. The adjusted VE was 71.9% (95% CI: [63.0-78.8]) against 30-day mortality and 70.0% (95% CI: [62.1-76.2]) against ICU admissions. Protection against influenza-associated hospitalizations was 58.2% (95% CI: [52.9-62.9]), while VE against outpatient visits was 44.8% (95% CI: [42.4-47.1]). Propensity score matching showed similar trend but generally lower VE estimates.Conclusions: Our findings confirm that the influenza vaccine remains highly effective in preventing severe outcomes, despite the reduced population uptake and increased disease burden. The methodology, consistent with our prior season’s analysis, underscores the reliability of these results. We conclude that enhancing vaccination coverage among the elderly is critical to mitigating the impact of severe seasonal epidemics.
- Open Access
- 16 December 2024
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 124 (6) , 578-581
Serological response to avian influenza viruses among occupationally exposed population in Taiwan, a longitudinal cohort study, 2021–2023
- 16 December 2024
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 124 (6) , 578-581
Open AccessSerological response to avian influenza viruses among occupationally exposed population in Taiwan, a longitudinal cohort study, 2021–2023
- Open Access
- 22 June 2023
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 123 (1) , 16-22
Sudan virus disease – A quick review
- 22 June 2023
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 123 (1) , 16-22
Open AccessSudan virus disease – A quick review
- Open Access
- 1 October 2019
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 87, 67-74
Comparative epidemiology of influenza B by lineage in intensive care unit-admitted patients with complications: A nationwide study in Taiwan, 2013–2017
- 1 October 2019
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 87, 67-74
Open AccessComparative epidemiology of influenza B by lineage in intensive care unit-admitted patients with complications: A nationwide study in Taiwan, 2013–2017
- Open Access
- 14 December 2011
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 11 (1) , 346
An outbreak of coxsackievirus A6 hand, foot, and mouth disease associated with onychomadesis in Taiwan, 2010
Background: In 2010, an outbreak of coxsackievirus A6 (CA6) hand, foot and mouth disease (HFMD) occurred in Taiwan and some patients presented with onychomadesis and desquamation following HFMD. Therefore, we performed an epidemiological and molecular investigation to elucidate the characteristics of this outbreak. Methods: Patients who had HFMD with positive enterovirus isolation results were enrolled. We performed a telephone interview with enrolled patients or their caregivers to collect information concerning symptoms, treatments, the presence of desquamation, and the presence of nail abnormalities. The serotypes of the enterovirus isolates were determined using indirect immunofluorescence assays. The VP1 gene was sequenced and the phylogenetic tree for the current CA6 strains in 2010, 52 previous CA6 strains isolated in Taiwan from 1998 through 2009, along with 8 reference sequences from other countries was constructed using the neighbor-joining command in MEGA software. Results: Of the 130 patients with laboratory-confirmed CA6 infection, some patients with CA6 infection also had eruptions around the perioral area (28, 22%), the trunk and/or the neck (39, 30%) and generalized skin eruptions (6, 5%) in addition to the typical presentation of skin eruptions on the hands, feet, and mouths. Sixty-six (51%) CA6 patients experienced desquamation of palms and soles after the infection episode and 48 (37%) CA6 patients developed onychomadesis, which only occurred in 7 (5%) of 145 cases with non-CA6 enterovirus infection (p < 0.001). The sequences of viral protein 1 of CA6 in 2010 differ from those found in Taiwan before 2010, but are similar to those found in patients in Finland in 2008. Conclusions: HFMD patients with CA6 infection experienced symptoms targeting a broader spectrum of skin sites and more profound tissue destruction, i.e., desquamation and nail abnormalities.
- 14 December 2011
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 11 (1) , 346
Open AccessAn outbreak of coxsackievirus A6 hand, foot, and mouth disease associated with onychomadesis in Taiwan, 2010
Background: In 2010, an outbreak of coxsackievirus A6 (CA6) hand, foot and mouth disease (HFMD) occurred in Taiwan and some patients presented with onychomadesis and desquamation following HFMD. Therefore, we performed an epidemiological and molecular investigation to elucidate the characteristics of this outbreak. Methods: Patients who had HFMD with positive enterovirus isolation results were enrolled. We performed a telephone interview with enrolled patients or their caregivers to collect information concerning symptoms, treatments, the presence of desquamation, and the presence of nail abnormalities. The serotypes of the enterovirus isolates were determined using indirect immunofluorescence assays. The VP1 gene was sequenced and the phylogenetic tree for the current CA6 strains in 2010, 52 previous CA6 strains isolated in Taiwan from 1998 through 2009, along with 8 reference sequences from other countries was constructed using the neighbor-joining command in MEGA software. Results: Of the 130 patients with laboratory-confirmed CA6 infection, some patients with CA6 infection also had eruptions around the perioral area (28, 22%), the trunk and/or the neck (39, 30%) and generalized skin eruptions (6, 5%) in addition to the typical presentation of skin eruptions on the hands, feet, and mouths. Sixty-six (51%) CA6 patients experienced desquamation of palms and soles after the infection episode and 48 (37%) CA6 patients developed onychomadesis, which only occurred in 7 (5%) of 145 cases with non-CA6 enterovirus infection (p < 0.001). The sequences of viral protein 1 of CA6 in 2010 differ from those found in Taiwan before 2010, but are similar to those found in patients in Finland in 2008. Conclusions: HFMD patients with CA6 infection experienced symptoms targeting a broader spectrum of skin sites and more profound tissue destruction, i.e., desquamation and nail abnormalities.
- 24 January 2010
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 42 (5) , 375-378
Outbreak of influenza in an overseas student travel group—Taiwan 2008
Influenza is a frequent cause of acute respiratory illness (ARI). In July 2008, we conducted a retrospective cohort study to investigate an influenza outbreak occurring in an overland travel group of overseas students. ARI was defined as the presence of any respiratory symptom such as cough, rhinorrhoea, sore throat or stuffy nose. Influenza-like illness (ILI) was defined as ARI plus fever > or =38 degrees C. Throat swabs were taken from symptomatic participants and a real-time polymerase chain reaction (RT-PCR) was performed. One hundred and seventy participants were interviewed. Forty-four (26%) had an ARI and 22 (13%) had an ILI. Of the 33 specimens collected, 18 (54%) were positive for influenza A/H3N2. Taiwanese group leaders had increased risk of acquiring both ARI and ILI (ARI relative risk (RR) 2.2, 95% confidence interval (CI) 1.3-3.7 and ILI RR 2.8, 95% CI 1.2-6.3). Fifteen participants were vaccinated. The vaccine effectiveness was 52% for ILI (p = 0.70). The outbreak stopped after cohorting and the use of surgical masks. Vaccination appeared to be effective in preventing infection.
- 24 January 2010
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 42 (5) , 375-378
Outbreak of influenza in an overseas student travel group—Taiwan 2008
Influenza is a frequent cause of acute respiratory illness (ARI). In July 2008, we conducted a retrospective cohort study to investigate an influenza outbreak occurring in an overland travel group of overseas students. ARI was defined as the presence of any respiratory symptom such as cough, rhinorrhoea, sore throat or stuffy nose. Influenza-like illness (ILI) was defined as ARI plus fever > or =38 degrees C. Throat swabs were taken from symptomatic participants and a real-time polymerase chain reaction (RT-PCR) was performed. One hundred and seventy participants were interviewed. Forty-four (26%) had an ARI and 22 (13%) had an ILI. Of the 33 specimens collected, 18 (54%) were positive for influenza A/H3N2. Taiwanese group leaders had increased risk of acquiring both ARI and ILI (ARI relative risk (RR) 2.2, 95% confidence interval (CI) 1.3-3.7 and ILI RR 2.8, 95% CI 1.2-6.3). Fifteen participants were vaccinated. The vaccine effectiveness was 52% for ILI (p = 0.70). The outbreak stopped after cohorting and the use of surgical masks. Vaccination appeared to be effective in preventing infection.